Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents

Assessment of the Ease of Use of Norditropin NordiFlex® Relative to the One of the Device Previously Used by Patients or Parents

This study is conducted in Europe. The aim of this study is to compare the easiness of use of Norditropin NordiFlex® device to the device previously used by patients or parents.

Inclusion Criteria:

• Children who can receive Norditropin® (somatropin) treatment according to the product labelling
• Treated with growth hormone for at least one year

Exclusion Criteria:

• Contraindications to Norditropin® growth hormone therapy
• Known or suspected hypersensitivity to somatropin or related products
• The receipt of any investigational medicinal product within 3 months prior to study start
• Life threatening disease, for example cancer
• Pregnancy or the intention of becoming pregnant